Literature DB >> 10501530

Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB).

T Imamura1, K Ishii, N Hirono, M Hashimoto, S Tanimukai, H Kazuai, T Hanihara, M Sasaki, E Mori.   

Abstract

To investigate the neurobiological bases of visual hallucinations in dementia with Lewy bodies (DLB), regional cerebral glucose metabolism was compared among three patient groups; DLB with visual hallucinations, DLB without visual hallucinations and Alzheimer's disease (AD) without visual hallucinations. The regional metabolism was significantly lower in both DLB groups than in the AD group in the primary visual area and the posterior temporal, parietal and lateral occipital association areas. The hypometabolism in the right posterior temporal and parietal areas was significantly milder in DLB with visual hallucinations than in DLB without hallucinations. The hypometabolism in the primary visual cortex and the relatively preserved metabolism in the right temporoparietal association cortices may be associated with the occurrence of visual hallucinations in DLB patients.

Entities:  

Mesh:

Year:  1999        PMID: 10501530     DOI: 10.1097/00001756-199906230-00020

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  22 in total

1.  Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

Authors:  Tamara G Fong; Sharon K Inouye; Weiying Dai; Daniel Z Press; David C Alsop
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

Review 2.  Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

Authors:  Peter J Nestor; Daniele Altomare; Cristina Festari; Alexander Drzezga; Jasmine Rivolta; Zuzana Walker; Femke Bouwman; Stefania Orini; Ian Law; Federica Agosta; Javier Arbizu; Marina Boccardi; Flavio Nobili; Giovanni Battista Frisoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-07       Impact factor: 9.236

3.  Creutzfeldt-Jacob disease misdiagnosed as dementia with Lewy bodies.

Authors:  Christoffer Kraemer; Klaudia Lang; Matthias Weckesser; Stefan Evers
Journal:  J Neurol       Date:  2005-03-17       Impact factor: 4.849

4.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

5.  Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.

Authors:  Karina Stavitsky; Patrick McNamara; Raymon Durso; Erica Harris; Sanford Auerbach; Alice Cronin-Golomb
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

Review 6.  Parkinson's disease as a disconnection syndrome.

Authors:  Alice Cronin-Golomb
Journal:  Neuropsychol Rev       Date:  2010-04-10       Impact factor: 7.444

7.  Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease.

Authors:  Micaela Mitolo; Joanne M Hamilton; Kelly M Landy; Lawrence A Hansen; Douglas Galasko; Francesca Pazzaglia; David P Salmon
Journal:  J Int Neuropsychol Soc       Date:  2016-05-25       Impact factor: 2.892

Review 8.  Visual hallucinations and the Charles Bonnet syndrome.

Authors:  Dominic H Ffytche
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

9.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

10.  Imaging improves diagnosis of dementia with lewy bodies.

Authors:  Masaru Tateno; Seiju Kobayashi; Toshikazu Saito
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.